{
}
Ukrainian President Volodimir Zelensky's push for NATO membership remains unfulfilled despite his extensive diplomatic efforts in Brussels. While NATO members reaffirmed that Ukraine's path to membership is "irreversible," significant reservations persist, particularly regarding ongoing conflict and potential escalation risks. Zelensky did secure some financial commitments, with NATO Secretary General Rutte noting that over half of the promised 40 billion euros has been disbursed.
MERCK KGAA's Capital Markets Day sparked a 7.6% market rise, despite dampened pharmaceutical expectations following setbacks in drug development. The Electronics division, particularly Semiconductor Materials, is projected to grow sales by 5-9% annually, while pharmaceuticals anticipate slight growth through licensing. Analysts remain optimistic, with target prices from DEUTSCHE BANK at €180 and GOLDMAN SACHS at €205, reflecting a calming effect from the event.
TME Pharma N.V. reported significant advancements in its clinical and regulatory efforts for NOX-A12, a treatment for glioblastoma, achieving a median overall survival of 19.9 months in a recent trial. The FDA granted Fast Track designation and cleared an IND application for a Phase 2 study, paving the way for accelerated development. The company also raised €5 million in funding, enhancing its financial position as it prepares for further clinical trials.
UBS has increased its price target for Hannover Re from 238 to 267 euros while maintaining a "Neutral" rating ahead of the third quarter results. Analyst Will Hardcastle noted that the sector's natural catastrophe budgets were largely depleted, with Hurricane Milton impacting fourth-quarter results, though improvements in tariffs are expected. Munich Re remains Hardcastle's preferred choice among European reinsurers.
UBS AG has raised its price target for Hannover Re shares from 238 to 267 euros while maintaining a "neutral" rating. The company's shares rose by 0.7% to EUR 257.20, indicating a potential upside of 3.81%. The Q3 2024 financial results are set to be released on November 11, 2024.
UBS AG has raised its target price for Hannover Re shares from 238 to 267 euros while maintaining a "neutral" rating ahead of the third-quarter results. The share price increased by 0.7% to EUR 257.10, indicating a potential upside of 3.85%. The Q3 2024 results are set to be released on November 11, 2024.
UBS AG has raised its price target for Munich Reinsurance Company shares from 525 to 565 euros, maintaining a "buy" rating. Analyst Will Hardcastle highlighted the stock as a top pick among European reinsurers, noting that the sector's natural catastrophe budgets are nearly exhausted for Q3, with improvements expected in rate statements. As of midday trading, shares fell 0.4% to EUR 502.60, still showing a potential rise of 12.42%.
UBS AG has raised its price target for Hannover Re from EUR 238 to EUR 267 while maintaining a "Neutral" rating. The share price rose by 0.7% to EUR 257.10, indicating an upside potential of 3.85%. Hannover Re is set to release its Q3 2024 figures on November 11, 2024.
UBS has increased its price target for Hannover Re from 238 to 267 euros while maintaining a "Neutral" rating ahead of the third-quarter results. Analyst Will Hardcastle noted that the sector's natural catastrophe budgets were largely depleted, with Hurricane Milton impacting fourth-quarter results, though improvements in tariffs are expected. Munich Re remains Hardcastle's preferred choice among European reinsurers.
UBS has increased its price target for Munich Re from 525 to 565 euros, maintaining a "buy" rating ahead of the third quarter results. Analyst Will Hardcastle highlighted the company as a top pick among European reinsurers, noting that the sector's natural catastrophe budgets are nearly exhausted, with Hurricane Milton's impact expected in the fourth quarter. Improvements in tariff statements are anticipated.
DEU
Country
The information provided herein is generated by experimental artificial intelligence and is for informational purposes only.
zelenski seeks nato membership amid ongoing war and cautious responses
United States Dollar
Euro
Nato B.V.
EU 40 VZW
DEU
RUS
BEL
UKR
USA
Olaf Scholz
Roberta Metsola
Joe Biden
Mark Rutte
Volodimir Zelensky
Show more
20:44 18.10.2024
merck kgaa navigates mixed signals amid growth in semiconductor materials
Euro
Thermo Fisher Scientific Inc.
Merck KGaA
BB Biotech AG
DEU
CHN
Belen Garijo
Helmut Gellermann
Show more
18:33 18.10.2024
TME Pharma advances glioblastoma treatment with promising NOX-A12 trial results
Euro
TME Pharma N.V.
Primarybid Ltd.
TME Pharma AG
TME Pharma Inc.
Singapore Eye Research Institute
National Cancer Institute
Atlas Special Opportunities II LLC
USA
FRA
DEU
SGP
Frank Giordano
Joe Biden
Show more
18:00 18.10.2024
ubs raises price target for hannover re while maintaining neutral rating
12:19 18.10.2024
ubs raises hannover re price target while maintaining neutral rating
12:13 18.10.2024
ubs raises hannover re target price but maintains neutral rating
12:13 18.10.2024
ubs raises price target for munich reinsurance company shares to 565 euros
12:13 18.10.2024
ubs raises price target for hannover re shares to 267 euros
12:13 18.10.2024
UBS raises Hannover Re price target while maintaining neutral rating
Euro
UBS SA
Munich ReThink GmbH
Hannover Rück SE
CHE
DEU
Hubert Dichtl
Thomas Müller
Warren Buffet
Will Hardcastle
Show more
11:22 18.10.2024
ubs raises price target for munich re to 565 euros
11:20 18.10.2024
Trending
Subcategory
Corporate News
Stock Market Updates
Industry Trends
Finance Mergers & Acquisitions
Global Financial Events
CEO Changes
Retail and Consumer Goods
Banking Regulations
Market Analysis and Predictions
Industry Mergers & Acquisitions
Global Trade Developments
Energy Sector Developments
Startups & Entrepreneurship
Government Policies
Supply Chain Management
Financial Scams and Security
Domestic Politics
Government Economic Policies
Central Bank Actions
Hedge Funds & Private Equity
Countries:
Companies:
Tesla, Inc.
Barclays PLC
JPMorgan Chase & Co.
Apple Inc.
BNP Paribas SA
UBS Group AG
NVIDIA Corporation
Morgan Stanley
Bank of America Corporation
Capital One Financial Corporation
The Goldman Sachs Group, Inc.
Deutsche Bank RV Global PP
Amazon.com, Inc.
Citigroup Inc.
Commerzbank AG
SpaceXCoin USD
Credit Suisse Real Estate Fund Siat
Wells Fargo & Company
UniCredit S.p.A.
Microsoft Corporation
Currencies:
United States Dollar
Euro
Chinese Yuan
Indian Rupee
Swiss Franc
British Pound Sterling
Vietnamese Đồng
Hong Kong Dollar
Australian Dollar
United Arab Emirates Dirham
Singapore Dollar
South Korean Won
Thai Baht
Norwegian Krone
Danish Krone
Swedish Krona
Russian Ruble
Ghanaian Cedi
Canadian Dollar
Turkish Lira
People: